| Patents for C07D 305 - Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms (5,442) |
|---|
| 07/18/2013 | US20130184238 Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy |
| 07/17/2013 | CN103209970A In situ chemiluminescent substrates and assays |
| 07/17/2013 | CN103203122A Method for separating and purifying high-purity natural substances from animals and plants by using liquid chromatography column |
| 07/16/2013 | US8487121 Chromane derivatives as TRPV3 modulators |
| 07/11/2013 | WO2013049154A3 Oxetane-containing compounds and compositions thereof |
| 07/11/2013 | US20130178639 Crystalline forms of dimethoxy docetaxel and methods for preparing the same |
| 07/10/2013 | EP2612857A1 Chemical synthesis and anti-tumor and anti-metastatic effects of dual functional conjugate |
| 07/10/2013 | CN103193735A Extraction method for taxus chinensis taxol activity extract |
| 07/10/2013 | CN102304105B Method for preparing high-purity Orlistat |
| 07/10/2013 | CN101896454B Activated methylene reagents and curable compositions prepared therefrom |
| 07/09/2013 | US8481759 Process for producing wine lactone |
| 07/09/2013 | US8481755 Activated methylene reagents and curable compositions prepared therefrom |
| 07/09/2013 | US8481589 Taxoid-based compositions |
| 06/27/2013 | WO2013092941A1 BENZYL SULFONAMIDE DERIVATIVES AS RORc MODULATORS |
| 06/27/2013 | WO2013034979A3 Crystalline forms of cabazitaxel |
| 06/26/2013 | CN103172654A Taxane compound and preparation method thereof |
| 06/26/2013 | CN103172625A Intermediate compound for cabazitaxel |
| 06/26/2013 | CN103172598A Method for extracting paclitaxel from taxus chinensis branch and leaf |
| 06/26/2013 | CN102219764B Method for separating and purifying paclitaxel industrially |
| 06/20/2013 | WO2013090276A1 Salen complexes with dianionic counterions |
| 06/20/2013 | WO2013088335A1 Crystalline form of cabazitaxel and process for preparing the same |
| 06/19/2013 | CN103168028A Cyclic amide derivative |
| 06/19/2013 | CN103159705A Preparation method for cabazitaxel intermediate |
| 06/19/2013 | CN103159704A Cabazitaxel intermediates and cabazitaxel intermediate preparation method |
| 06/19/2013 | CN102363612B Method for extracting taxol simply, conveniently and efficiently |
| 06/19/2013 | CN101663287B Semi-synthetic process for the preparation of taxane derivatives |
| 06/18/2013 | US8466300 Processes for the production of hydrogenated products |
| 06/13/2013 | WO2013054204A3 A process for making an intermediate of cabazitaxel |
| 06/12/2013 | CN103145654A Docetaxel semi-synthesis method |
| 06/12/2013 | CN103145653A High-efficiency extraction and purification process for 10-deacetyl baccatin (10-DAB) III |
| 06/12/2013 | CN103145652A Method of extracting paclitaxel and derivatives thereof from taxus plants |
| 06/06/2013 | WO2013080217A2 Crystalline forms of carbazitaxel and process for preparation thereof |
| 06/05/2013 | CN103130753A Semi-synthesis method of antitumor drug taxol |
| 06/05/2013 | CN102250047B Preparation method of taxol compound |
| 06/04/2013 | US8455061 Optically active compound having polymerizable group and its polymer |
| 05/30/2013 | WO2013056245A3 Stearate compounds |
| 05/30/2013 | CA2856522A1 Disubstituted beta-lactones as inhibitors of n-acylethanolamine acid amidase (naaa) |
| 05/29/2013 | EP2595973A1 A process for the production of carnitine from -lactones |
| 05/29/2013 | EP2595951A1 A process for the production of carnitine |
| 05/28/2013 | CA2756603C Process for making crystalline docetaxel trihydrate |
| 05/23/2013 | US20130131132 N-substituted aminobenzocycloheptene, aminotetraline, aminoindane and phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy |
| 05/21/2013 | US8445703 Process for beta-lactone production |
| 05/16/2013 | WO2013069027A1 Processes for the preparation of cabazitaxel involving c(7) -oh and c(13) -oh silylation or just c(7) -oh silylation |
| 05/16/2013 | US20130122110 Anti-human urothelial carcinoma of supercritical carbon dioxide extract of cinnamomum subavenium, and the preparation process and uses |
| 05/15/2013 | EP2590958A1 In situ chemiluminescent substrates and assays |
| 05/15/2013 | EP2590930A1 Spirocyclically substituted 1,3-propane dioxide derivatives, methods for the production thereof and use of the same as medicament |
| 05/15/2013 | CN103102333A Production method for alkyl ketene dimer |
| 05/14/2013 | US8440608 Beta-substituted tetrandropyrana (on) s and method for the synthesis and the use thereof |
| 05/10/2013 | WO2013065070A1 Amorphous form of cabazitaxel and process for its preparation |
| 05/10/2013 | WO2013064538A1 Substituted benzylamine compounds, their use in medicine, and in particular the treatment of hepatitis c virus (hcv) infection |
| 05/10/2013 | WO2013063894A1 Method for modifying titanium silicon molecular sieves |
| 05/10/2013 | WO2013063893A1 Process for modifying ts-1 based on mixed solution of quaternary ammonium salt and inorganic base |
| 05/10/2013 | CA2853006A1 Substituted benzylamine compounds, their use in medicine, and in particular the treatment of hepatitis c virus (hcv) infection |
| 05/08/2013 | CN103097333A Spirocyclically substituted 1,3-propane dioxide derivatives, methods for the production thereof and use of the same as medicament |
| 05/08/2013 | CN103087013A Paclitaxel preparation method |
| 05/08/2013 | CN103086924A Synthetic method of docetaxel and intermediate of docetaxel |
| 05/02/2013 | US20130109870 Amorphous form of cabazitaxel and process for its preparation |
| 04/30/2013 | US8431726 Preparation method of (3S,4S)-3-hexyl-4-((R)-2-hydroxytridecyl)-oxetan-2-one and the product of that method |
| 04/30/2013 | US8431725 Purification of lactide rich streams |
| 04/25/2013 | WO2013059651A1 Bifunctional compounds |
| 04/25/2013 | WO2013057260A1 Cabazitaxel, related compounds and methods of synthesis |
| 04/25/2013 | WO2013056662A1 Novel taxane derivative and preparation method therefor |
| 04/25/2013 | US20130102657 Anti-angiogenic compositions and methods of use |
| 04/24/2013 | CN103058961A Method for extracting paclitaxel from taxus yunnanensis |
| 04/24/2013 | CN103058960A Cabazitaxel polymorphic form and preparation method thereof |
| 04/24/2013 | CN101948450B Method for preparing orlistat |
| 04/23/2013 | US8425988 Polymerizable liquid crystal compound, polymerizable liquid crystal composition and anisotropic polymer |
| 04/18/2013 | WO2013054204A2 A process for making an intermediate of cabazitaxel |
| 04/18/2013 | CA2851179A1 A process for making an intermediate of cabazitaxel |
| 04/17/2013 | CN103044364A Cabazitaxel amorphous crystal and preparation method thereof |
| 04/17/2013 | CN103044363A Paclitaxel derivative as well as preparation method and application thereof |
| 04/17/2013 | CN103040850A Methionine-antitumor compound medicine and preparation method thereof |
| 04/11/2013 | US20130090484 Process for making an intermediate of cabazitaxel |
| 04/10/2013 | CN103030613A Method for purifying lipstatin |
| 04/09/2013 | US8415388 Pharmaceutical compositions containing paclitaxel orotate |
| 04/03/2013 | CN103012331A Preparation method of cabazitaxel and intermediate thereof |
| 04/03/2013 | CN103012330A Preparation method of taxol anticancer drugs XRP6258 |
| 04/03/2013 | CN103012329A Preparation method of taxol anticancer drugs Cabazitaxel XRP6258 |
| 04/03/2013 | CN103012328A Method for preparing second-generation taxol anticancer drug Cabazitaxel |
| 04/02/2013 | US8410294 Method for preparing highly pure anhydrous crystalline docetaxel |
| 04/02/2013 | US8410291 Processes for the production of hydrogenated products |
| 03/27/2013 | CN103003257A A process for the production of carnitine from [beta] -lactones |
| 03/27/2013 | CN102993137A Method for industrial semi-synthetic docetaxel |
| 03/27/2013 | CN102993136A Preparation method for 7-alpha hydroxyl taxane |
| 03/27/2013 | CN102993135A Method for purifying orlistat |
| 03/27/2013 | CN102993134A Purification method for lipstatin |
| 03/21/2013 | US20130072677 Novel hydroxamic acid derivative |
| 03/20/2013 | CN102974295A Reactor suitable for viscous material participation or generation |
| 03/19/2013 | US8399687 Processes for the production of hydrogenated products |
| 03/19/2013 | US8399507 Antidiabetic tricyclic compounds |
| 03/14/2013 | WO2013034979A2 Crystalline forms of cabazitaxel |
| 03/14/2013 | US20130065955 Crystalline forms of cabazitaxel |
| 03/14/2013 | CA2845380A1 Crystalline forms of cabazitaxel |
| 03/13/2013 | CN102971285A A process for the production of carnitine |
| 03/13/2013 | CN102964316A Radical protection method for synthesis of docetaxel |
| 03/13/2013 | CN102962026A Equipment and method for continuously preparing high-purity AKD (Alkyl Ketene Dimer) without solvent |
| 03/13/2013 | CN102161637B Photoactive compound |
| 03/12/2013 | US8394994 Method for producing of 2-alkyl-2-cycloalken-1-one |
| 03/12/2013 | US8394418 Combination preparation of a biological response modifier and an anticancer agent and uses thereof |
| 03/07/2013 | WO2013029723A1 Novel photoactivatable paclitaxel derivatives and uses thereof, in particular in cellbiology and cancer treatment |